Abstract:Streptococcus pyogenes is a Gram-positive beta-hemolytic bacteria, also known as group A streptococci, that causes a range of infections. The most common presentation is acute pharyngitis; however, it is also implicated in skin and soft tissue infections, and less commonly bacteremia, osteomyelitis, pneumonia, otitis media and sinusitis. Group A streptococci infections of the central nervous system are exceedingly rare in the antibiotic era. The mechanism of infection is typically contiguous spread from existing infection or via direct inoculation. We present a case of an 81-year-old female with a past medical history of dementia, transient ischemic attacks, type 2 diabetes mellitus, hypertension, descending thoracic aortic aneurysm status post-stent placement in 2008, hepatitis C and hyperlipidemia who initially presented after being found unresponsive at home. Her initial symptoms were primarily of altered mentation and on evaluation was found to be in septic shock with suspicion of meningoencephalitis. Her initial workup included a computed tomography of head which was remarkable for left and right mastoid effusions. A lumbar puncture was performed with cloudy purulent fluid, an elevated white blood cell count, low glucose and elevated protein. The patient was initially started on broad spectrum coverage and soon had 4/4 blood cultures and cerebrospinal fluid cultures growing Streptococcus pyogenes. Empiric vancomycin, ceftriaxone and ampicillin were administered but switched to penicillin G in the setting of elevated total bilirubin and septic shock with multi-organ failure and narrowed to ampicillin-sulbactam based on sensitivities. Unfortunately, the patient deteriorated further due to septic shock and multi-organ failure and later died in the medical intensive care unit.

Host Defense Susceptibility and Invasive Streptococcal Infections

Interplay between group A Streptococcus and host innate immune responses

Pathogenesis, epidemiology and control of Group A Streptococcus infection

The intricate pathogenicity of Group A Streptococcus: A comprehensive update

Group A Streptococcus interactions with the host across time and space

Responses of innate immune cells to group A Streptococcus

Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain

Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention

Interaction mechanism between surface protein and host in group A streptococcus

Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen

The Thousand Faces of Invasive Group A Streptococcal Infections: Update on Epidemiology, Symptoms, and Therapy

Streptococcal infection and autoimmune diseases

Streptococci and the complement system: interplay during infection, inflammation and autoimmunity

Glycan‐metabolizing enzymes in microbe–host interactions: the Streptococcus pneumoniae paradigm

The AgI/II family adhesin AspA is required for respiratory infection by Streptococcus pyogenes

Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas

Streptococcus pyogenes and invasive central nervous system infection

Group A Streptococcus strains causing meningitis without distinct invasive phenotype

Immunomodulating Enzymes from Streptococcus pyogenes—In Pathogenesis, as Biotechnological Tools, and as Biological Drugs

Global and local epidemiology of Group A Streptococcus indicates that naturally-acquired immunity is enduring and strain-specific

Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets